Shaanxi Micot Pharmaceutical Technology Co., Ltd. (HKG:2335)

HKG:2335 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep 9, 2026	Dec 31, 2025	Dec 31, 2024
Debt / Equity Ratio	0.00	-1.26	0.59
Net Debt / Equity Ratio	-1.25	-1.01	-0.83
Net Debt / EBITDA Ratio	4.55	-6.48	0.87
Net Debt / FCF Ratio	-51.70	-7.05	0.96
Quick Ratio	9.00	0.89	2.31
Current Ratio	9.11	0.98	2.39
Return on Assets (ROA)	-	-33.17%	-
Return on Capital Employed (ROCE)	-23.10%	-236.10%	-74.30%

Yields

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep 9, 2026	Dec 31, 2025	Dec 31, 2024
Buyback Yield / Dilution	-	-3.71%	-

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error